The present invention relates to substituted 5,6-dihydroimidazo[1,5-f]pteridines of formula I:which are useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the invention.